CannaPharmaRX, Inc. CPMD OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score

22/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

CannaPharmaRX, Inc. (CPMD) .

本页证实的标准:

VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分： 20/100 其中 0/7 项标准通过。

SharesGrow 7-Criteria Score

22/100

SG Score

View full scorecard →

—

价值

N/A

No coverage

—

未來

N/A

No coverage

✗

过去

25/100

→ Income

✗

健康

0/100

Debt-to-Equity & liquidity

→ Health

✗

护城河

15/100

→ Income

成长

58/100

→ Income

✗

收入

10/100

→ Income

估值概览 — CPMD

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率1.85

EV/EBITDA0.0

每股数据

EPS (TTM)$-0.02

每股账面价值$0.00

每股营收$0.00

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

EPS：实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2016	$-0.06	$0.00	$-1M	-
2017	$0.00	$0.00	$-6.63K	-
2018	$-0.17	$0.00	$-3.09M	-
2019	$-0.66	$0.00	$-20.45M	-
2020	$-0.49	$0.00	$-19.89M	-
2021	$-0.12	$0.00	$-8.83M	-
2022	$-0.04	$0.00	$-8.53M	-
2023	$0.01	$0.00	$3.69M	-
2024	$-0.02	$820.14K	$-9.91M	-1207.8%
2025	$-0.02	$1.36M	$-11.13M	-817.2%